Literature DB >> 19536458

The role of ethnicity, age and gender in venous thromboembolism.

Martina Montagnana1, Emmanuel J Favaloro, Massimo Franchini, Gian Cesare Guidi, Giuseppe Lippi.   

Abstract

Venous thromboembolism, including both deep venous thrombosis and pulmonary embolism, is the leading cause of preventable in-hospital mortality. In the inexorable progress towards individualization of risk and personalized medicine, several congenital and acquired risk factors have been identified. However, the influence of some demographical variables, especially ethnicity, age and gender, has largely been under appreciated. Although the incidence of venous thromboembolism varies widely among diverse racial/ethnic cohorts, it appears globally highest in Blacks, is intermediate in Caucasians and is lowest in Asians. The incidence and prevalence of venous thromboembolism is also strongly age-related, increasing nearly 90 fold from <15 to >80 years old. Definitive data on the relative frequency of venous thromboembolism across genders is lacking. Some studies report that gender is not an independent risk factor of venous thromboembolism, while others conclude that female gender might be a protective variable. The purpose of this review is to assess the relationship between such demographic variables and venous thromboembolism.

Entities:  

Mesh:

Year:  2010        PMID: 19536458     DOI: 10.1007/s11239-009-0365-8

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  105 in total

1.  Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale.

Authors:  E Oger
Journal:  Thromb Haemost       Date:  2000-05       Impact factor: 5.249

2.  Use of first nucleotide change technology to determine the frequency of factor V Leiden in a population of Australian blood donors.

Authors:  N M Pecheniuk; N A Marsh; T P Walsh; J L Dale
Journal:  Blood Coagul Fibrinolysis       Date:  1997-11       Impact factor: 1.276

3.  Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups.

Authors:  Chi Chiu Mok; Sandy Shuk Kuen Tang; Chi Hung To; Michelle Petri
Journal:  Arthritis Rheum       Date:  2005-09

Review 4.  Racial disparities in risk factors for thrombosis.

Authors:  Haruka Itakura
Journal:  Curr Opin Hematol       Date:  2005-09       Impact factor: 3.284

5.  An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study.

Authors:  M M Samama
Journal:  Arch Intern Med       Date:  2000 Dec 11-25

6.  The effect of folic acid fortification on plasma folate and total homocysteine concentrations.

Authors:  P F Jacques; J Selhub; A G Bostom; P W Wilson; I H Rosenberg
Journal:  N Engl J Med       Date:  1999-05-13       Impact factor: 91.245

7.  Venous thromboembolism: regional differences in the nationwide inpatient sample, 1993 to 2000.

Authors:  Mary C Proctor; Reid M Wainess; Peter K Henke; Gilbert R Upchurch; Thomas W Wakefield
Journal:  Vascular       Date:  2004 Nov-Dec       Impact factor: 1.285

8.  Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial.

Authors:  Katherine L Tucker; Beth Olson; Peter Bakun; Gerard E Dallal; Jacob Selhub; Irwin H Rosenberg
Journal:  Am J Clin Nutr       Date:  2004-05       Impact factor: 7.045

Review 9.  Thrombosis and antithrombotic therapy in women.

Authors:  Alison L Bailey; Dawn C Scantlebury; Susan S Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-16       Impact factor: 8.311

Review 10.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

View more
  31 in total

Review 1.  Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapy.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

Review 2.  Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

3.  Futility of testing for factor V Leiden.

Authors:  Emmanuel J Favaloro; David McDonald
Journal:  Blood Transfus       Date:  2012-07       Impact factor: 3.443

4.  Incidence and prevention of postoperative venous thromboembolism: are they meaningful quality indicators in Japanese health care settings?

Authors:  Susumu Kunisawa; Hiroshi Ikai; Yuichi Imanaka
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

5.  Male mice have increased thrombotic potential: sex differences in a mouse model of venous thrombosis.

Authors:  Christine M Alvarado; Jose A Diaz; Angela E Hawley; Shirley K Wrobleski; Robert E Sigler; Daniel D Myers
Journal:  Thromb Res       Date:  2011-02-05       Impact factor: 3.944

6.  Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data.

Authors:  David C Kaelber; Wendy Foster; Jason Gilder; Thomas E Love; Anil K Jain
Journal:  J Am Med Inform Assoc       Date:  2012-07-03       Impact factor: 4.497

7.  National and Regional Trends in Deep Vein Thrombosis Hospitalization Rates, Discharge Disposition, and Outcomes for Medicare Beneficiaries.

Authors:  Karl E Minges; Behnood Bikdeli; Yun Wang; Robert R Attaran; Harlan M Krumholz
Journal:  Am J Med       Date:  2018-06-23       Impact factor: 4.965

Review 8.  Alcohol consumption and venous thromboembolism: friend or foe?

Authors:  Giuseppe Lippi; Camilla Mattiuzzi; Massimo Franchini
Journal:  Intern Emerg Med       Date:  2015-10-07       Impact factor: 3.397

9.  Value of venous color flow duplex scan as initial screening test for geriatric inpatients with clinically suspected pulmonary embolism.

Authors:  Raghid Kreidy; Elias Stephan; Pascale Salameh; Mirna Waked
Journal:  Vasc Health Risk Manag       Date:  2011-09-15

10.  Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria.

Authors:  Sarah O John-Olabode; Kehinde S Okunade; Ayorinde James; Gbenga Olorunfemi; Obiefuna I Ajie; Akinniyi A Osuntoki; Alani S Akanmu
Journal:  J Blood Med       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.